Pseudocholinesterase activity in thyroid disease.
The present evidence indicates that serum pseudocholinesterase activity is increased to about 20% above the normal level in thyrotoxicosis and decreased by about 30% in myxoedema. Treatment restores the esterase level to the average mean activity of random normal as the patient becomes euthyroid. There is no evidence in the present investigation that any of the pseudocholinesterase variants modify these conclusions.
D002802:Cholinesterases; D004796:Clinical Enzyme Tests; D006801:Humans; D013959:Thyroid Diseases
D002802:Cholinesterases
Br Med J. 1951 Oct 6;2(4735):816-9
14869729
Can J Biochem Physiol. 1957 Dec;35(12):1305-20
13479831
Br J Nutr. 1954;8(2):79-82
13160306
Acta Med Acad Sci Hung. 1954;5(1-2):109-15
13137921
Br Med J. 1951 Oct 6;2(4735):812-6
14869728
Blood. 1951 Dec;6(12):1260-73
14886399
Acta Genet Stat Med. 1964;14:281-5
14220468
Nature. 1961 Jul 29;191:496-8
13711731
Ann Hum Genet. 1963 Jun;26:359-82
13952923
Lancet. 1950 May 13;1(6611):908-9
15416075
Can J Biochem Physiol. 1957 Jun;35(6):339-46
13437188